Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR

Published:2013-01-14 Issue:5 Volume:110 Page:1815-1820
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Ferraro D. A.,Gaborit N.,Maron R.,Cohen-Dvashi H.,Porat Z.,Pareja F.,Lavi S.,Lindzen M.,Ben-Chetrit N.,Sela M.,Yarden Y.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference26 articles.

1. Roles for Growth Factors in Cancer Progression

2. EGFR Antagonists in Cancer Treatment

3. Cancer therapeutic antibodies come of age: Targeting minimal residual disease

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the therapeutic potential for cancer treatment and revealing the mechanism of telisotuzumab by atomic force microscopy;Microchemical Journal;2024-11

2. A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib;Cell Reports Medicine;2024-08

3. The Agonistic Activity of the Human Epidermal Growth Factor is Reduced by the D46G Substitution;Protein & Peptide Letters;2024-07

4. Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches;International Journal of Molecular Sciences;2024-02-22

5. Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer;Technology in Cancer Research & Treatment;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3